- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06150521
Hysteroscopic Myomectomy for Submucosal Myomas Without Energy Instruments
Uterine fibroid are the most common benign tumor in the female reproductive system. Although many patients with uterine fibroid do not need to be treated because they are asymptomatic, some patients can experience compression, menorrhagia, pain, irregular bleeding or infertility. The symptoms caused by uterine fibroid are related to its location and size. Submucous fibroids constitute 5-10% of all uterine fibroids.The submucous hysteromyoma is the most likely to cause symptoms, often leads to menorrhagia, irregular bleeding or infertility.
Hysteroscopic myomectomy is a commonly used minimally invasive procedure. The submucous myoma can be resected out by endoscopic resectoscope with electricloop (unipolar and bipolar) . It can preserve the uterus and fertility, also effectively alleviate symptoms.
However, some specific complications have also followed,such as: hemorrhage,uterine perforation, pneumonedema,infections,adhesions,etc. Uterine perforation occurs when the electrode is working, there is a high risk of injury to adjacent anatomical structures. And even without perforation, sometimes thermal injury to adjacent organs may still be discovered in a few days after surgery.In addition,Many scholars have found that hysteroscopic electromyectomy has a higher risk of intrauterine adhesion than other intrauterine operations.
In order to reduce the damage caused by energy source, especially the adverse effects of thermal damage on the endometrium, the new methods of hysteroscopic myomectomy currently include: the hysteroscopic tissue removal (HTR) system, the cold loop myomectomy, the Hysteroscopy Endo Operative system (HEOS),etc. Existing studies show that,These manipulation techniques did not cause the myometrium damage by radiofrequency energy source, greatly reducing the risk of postoperative intrauterine adhesions. The cold knife hysteroscopic myomectomy in this study is a series of procedures using cold instruments(mechanically, with scissor, grasping or morcellation) to remove uterine submucosal fibroids. The purpose of this surgical technique is to make the operation safe and effective, with greater emphasis on the anatomical and physiological integrity of the myometrial and endometrial layers. This study aims to evaluate the safety and efficacy of cold knife hysteroscopic myomectomy.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Yiwu, Zhejiang, China, 322000
- Xu Wanwan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
All patients who underwent cold knife hysteroscopic myomectomy and excised tissue that showed pathology confirmation of leiomyoma.
Exclusion Criteria:
Patients has gynecologic malignancy.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
The hysteroscopic myomectomy group
Patients underwent cold knife hysteroscopic myomectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate
Time Frame: On the 1 day of surgery
|
Total removal of intrauterine pathology with cold knife hysteroscopic myomectomy was defined as a successful operation.
During the operation, whether the fibroids were successfully removed by B-ultrasound examination and naked eye
|
On the 1 day of surgery
|
|
failure rate
Time Frame: On the 1 day of surgery
|
Using the cold knife method failed to remove the fibroids.
During operative transfer to other surgical methods to remove submucosal fibroids, such as electrical cutting
|
On the 1 day of surgery
|
|
Incidence of complications
Time Frame: On the 1 day of surgery and on 1 day after surgery
|
hemorrhage, pneumonedema, or perforation were registered
|
On the 1 day of surgery and on 1 day after surgery
|
|
surgical bleeding
Time Frame: On the 1 day of surgery and on 1 day after surgery
|
Through the intraoperative blood loss assessment and preoperative and postoperative hemoglobin comparison
|
On the 1 day of surgery and on 1 day after surgery
|
|
Checklist of symptom relief
Time Frame: followed-up at 3, 6,12,24 months after surgery
|
postoperative menstrual volume, menstrual period, anemia, postoperative fertility, postoperative intrauterine adhesions.
|
followed-up at 3, 6,12,24 months after surgery
|
Collaborators and Investigators
Investigators
- Study Chair: Wanwan Xu, Doctor, The Fourth Affiliated Hospital Zhejiang University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- K2023084
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.